Syncom Formulation P/E forward ratio data released
Syncom Formulation P/E forward ratio data released.
The forward price-to-earnings ratio for Syncom Formulation (India) Ltd. has been updated on TradingView, reflecting market expectations. While no fundamental change in operations is indicated, the valuation metric may influence short-term trading sentiment. Traders may assess the stock against sector peers with average P/E around 28x.
📊 STOCKS: SYNCOMF | 🏢 SECTOR: Pharma | #LOWIMPACT #Valuation
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.